RAPT Stock Analysis: Buy, Sell, or Hold?
RAPT - RAPT Therapeutics, Inc. Common Stock
$57.68
0.05 (0.09%)
▲
HOLD
MODERATE Confidence
Last Updated: January 30, 2026
Earnings: Mar 05, 2026
Get Alerted When RAPT Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD - EXTENDED: RAPT is 8.7% above fair value ($53.06). Fundamentals are solid but entry is stretched. Hold existing positions; wait for pullback to add new shares.
📊 HOLD - EXTENDED: RAPT is 8.7% above fair value ($53.06). Fundamentals are solid but entry is stretched. Hold existing positions; wait for pullback to add new shares.
In-depth Analysis How we analyze
Valuation Analysis: RAPT is currently trading at $57.68, which is considered extended relative to its 30-day fair value range of $30.31 to $53.06.
Technical Outlook: Technically, RAPT is in a strong uptrend. The price is approaching resistance at $57.70. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: RAPT has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, RAPT is in a strong uptrend. The price is approaching resistance at $57.70. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: RAPT has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
EXTENDED
Fair Price Range
$30.31 -
$53.06
Company Quality Score
59/100
(HOLD)
Volume Confirmation
MODERATE
Confidence Score
47.4%
Protect Your Profits
RAPT is technically overbought (RSI 80). Consider hedging now to protect against a potential pullback while keeping your upside.
View Profit Protection PlanAll Signals
- BEARISH: Price extended above range (+8.7% above fair value)
- BULLISH: Strong technical setup (60/100)
- NEUTRAL: Near Wall St target ($58.00)
Fair Price Analysis
30-Day Fair Range
$30.31 -
$53.06
Current vs Fair Value
EXTENDED
Support & Resistance Levels
Support Level
$32.00
Resistance Level
$57.71
Current Trend
Strong Uptrend
Fundamental Context
Forward P/E (Next Year Est.)
-18.56
Wall Street Target
$58.00
(+0.6%)
Revenue Growth (YoY)
-100.0%
Last updated: January 30, 2026 5:37 PM ET
Data refreshes hourly during market hours. Next update: 6:37 PM
Data refreshes hourly during market hours. Next update: 6:37 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is RAPT showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
SRPT
Sarepta Therapeutics Inc |
STRONG BUY
26 analysts |
$21 | 54 HOLD |
|
ALNY
Alnylam Pharmaceuticals … |
STRONG BUY
33 analysts |
$486 | 45 HOLD |
|
VRTX
Vertex Pharmaceuticals I… |
BUY
34 analysts |
$500 | 62 BUY |
|
IONS
Ionis Pharmaceuticals Inc |
BUY
26 analysts |
$91 | 64 BUY |
|
REGN
Regeneron Pharmaceutical… |
STRONG BUY
25 analysts |
$830 | 52 HOLD |
Advanced RAPT Option Strategies
Professional options setups generated by AI based on today's RAPT price and gamma walls.
